151. HSV susceptibility to acyclovir - genotypic and phenotypic characterization.
- Author
-
Vikas R, Prabhu SG, Mudgal PP, Shetty U, Karunakaran K, Jagadesh A, Auti A, Stansilaus RP, Nair S, and Arunkumar G
- Subjects
- Acyclovir therapeutic use, Adult, Antiviral Agents pharmacology, Antiviral Agents therapeutic use, Drug Resistance, Viral, Female, Genes, Viral, Herpes Simplex diagnosis, Herpes Simplex drug therapy, Herpesvirus 1, Human drug effects, Herpesvirus 1, Human genetics, Humans, Male, Mutation, Retrospective Studies, Sequence Analysis, DNA, Young Adult, Acyclovir pharmacology, Genotype, Herpes Simplex virology, Herpesvirus 2, Human drug effects, Herpesvirus 2, Human genetics, Microbial Sensitivity Tests, Phenotype
- Abstract
Background: Infections due to drug-resistant herpes simplex viruses (HSV) represent an important clinical concern, especially in immunocompromised patients. The present study was aimed at detecting acyclovir (ACV) susceptibility in HSV clinical samples., Methods: A total of 13 HSV-positive clinical samples (5 HSV-1 and 8 HSV-2) recovered from patients (1 immunocompromised and 12 of unknown immune status) were included in the study. The genotypic analysis involved an initial UL23 (thymidine kinase) gene sequencing, followed by a confirmatory phenotypic assay using plaque reduction technique., Results: Two novel amino acid changes, A37V and H283N, were detected in HSV-1 positive clinical samples, which were found to be susceptible to acyclovir (half maximal effective concentration = 1.5 µM) by plaque reduction assay., Conclusions: These two novel amino acid changes could be therefore considered as natural polymorphisms, a phenomenon widely associated with the HSV-UL23 gene.
- Published
- 2019
- Full Text
- View/download PDF